Canton Hathaway’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Hold
6,780
0.2% 64
2026
Q1
$626K Hold
6,780
0.13% 81
2025
Q4
$693K Sell
6,780
-1,170
-15% -$105K 0.13% 78
2025
Q3
$497K Sell
7,950
-920
-10% -$50K 0.1% 95
2025
Q2
$462K Buy
8,870
+590
+7% +$26.4K 0.09% 98
2025
Q1
$353K Buy
+8,280
New +$357K 0.07% 108
2024
Q3
Sell
-2,050
Closed -$59K 256
2024
Q2
$59K Buy
+2,050
New +$47.7K 0.02% 150
2021
Q3
Sell
-220
Closed -$27K 291
2021
Q2
$27K Buy
+220
New +$29.6K 0.01% 193

Other funds holding GH

Canton Hathaway's GH Position: Q2 2026 in Review

Canton Hathaway held its Guardant Health (GH) position steady in Q2 2026 at 6,780 shares worth $1.02M. The position accounts for 0.2% of the portfolio, ranked #64.

Canton Hathaway first reported a position in GH in Q2 2021 and has held it in 8 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Canton Hathaway held 6,780 shares of Guardant Health worth $1.02M as of Q2 2026.
  • Canton Hathaway left its Guardant Health share count unchanged in Q2 2026.
  • Guardant Health made up 0.2% of Canton Hathaway's portfolio in Q2 2026, its #64 holding.
  • Canton Hathaway first reported a position in Guardant Health in Q2 2021 and has held it in 8 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Canton Hathaway's 13F filing for Q2 2026, filed 6 Aug 2026.